News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Derma Sciences, Inc. (DSCI) CEO Highlights Rapid Growth of MEDIHONEY Products in Presentation at Comvita Annual Meeting



7/25/2013 8:17:14 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, announces that its chief executive officer, Edward J. Quilty, highlighted the rapid growth of MEDIHONY® Dressings with medical grade Manuka (Leptospermum) Honey, and the rewarding relationship between Derma Sciences and Comvita Limited in a presentation at Comvita’s annual shareholders’ meeting in New Zealand yesterday.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES